Jana Kozakova

The impact of the COVID-19 pandemic on the incidence of invasive pneumococcal disease in the Czech Republic and whole genome sequencing analysis of Streptococcus pneumoniae serotypes 3 and 19A from 2018-2024.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: July 03, 2026

Surveillance of invasive pneumococcal disease and serotypes coverage of pneumococcal vaccines in the Czech Republic between 2007 and 2024.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: April 20, 2026

Whole genome sequencing analysis of Streptococcus pneumoniae populations of serotypes 10A, 11A, 12F, 15B, and 33F involved in invasive pneumococcal disease in the Czech Republic in 2013-2023.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: January 15, 2026

Comparison of Streptococcus pneumoniae isolates occurring in optochin-susceptible and optochin-resistant variants by analyzing whole-genome sequencing data.

Journal: Microbiology spectrum

Published: February 25, 2025

Streptococcus pneumoniae serotypes 8 and 22F causing invasive pneumococcal disease in the Czech Republic in 2014-2020: whole genome sequencing (WGS) analysis.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: July 26, 2024

Prevalence of the M1UK sublineage among emm1 Streptococcus pyogenes invasive strains isolated in the Czech Republic from December 2022 to May 2023.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: July 26, 2024

Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study.

Journal: Infection

Published: July 24, 2024

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.

Journal: The Lancet. Infectious diseases

Published: June 01, 2024

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.

Journal: The Lancet. Infectious diseases

Published: May 31, 2024

The impact of the COVID-19 pandemic on the incidence of invasive pneumococcal disease in the Czech Republic and whole genome sequencing analysis of Streptococcus pneumoniae serotypes 3 and 19A from 2018-2024.

The impact of the COVID-19 pandemic on the incidence of invasive pneumococcal disease in the Czech Republic and whole genome sequencing analysis of Streptococcus pneumoniae serotypes 3 and 19A from 2018-2024.

Surveillance of invasive pneumococcal disease and serotypes coverage of pneumococcal vaccines in the Czech Republic between 2007 and 2024.

Surveillance of invasive pneumococcal disease and serotypes coverage of pneumococcal vaccines in the Czech Republic between 2007 and 2024.

Whole genome sequencing analysis of Streptococcus pneumoniae populations of serotypes 10A, 11A, 12F, 15B, and 33F involved in invasive pneumococcal disease in the Czech Republic in 2013-2023.

Whole genome sequencing analysis of Streptococcus pneumoniae populations of serotypes 10A, 11A, 12F, 15B, and 33F involved in invasive pneumococcal disease in the Czech Republic in 2013-2023.

Comparison of Streptococcus pneumoniae isolates occurring in optochin-susceptible and optochin-resistant variants by analyzing whole-genome sequencing data.

Comparison of Streptococcus pneumoniae isolates occurring in optochin-susceptible and optochin-resistant variants by analyzing whole-genome sequencing data.

Streptococcus pneumoniae serotypes 8 and 22F causing invasive pneumococcal disease in the Czech Republic in 2014-2020: whole genome sequencing (WGS) analysis.

Streptococcus pneumoniae serotypes 8 and 22F causing invasive pneumococcal disease in the Czech Republic in 2014-2020: whole genome sequencing (WGS) analysis.

Prevalence of the M1UK sublineage among emm1 Streptococcus pyogenes invasive strains isolated in the Czech Republic from December 2022 to May 2023.

Prevalence of the M1UK sublineage among emm1 Streptococcus pyogenes invasive strains isolated in the Czech Republic from December 2022 to May 2023.

Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study.

Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study.

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.

Posibilities for use of whole genome sequencing (WGS) for the analysis of Streptococcus pneumoniae isolates.

Posibilities for use of whole genome sequencing (WGS) for the analysis of Streptococcus pneumoniae isolates.

Molecular Epidemiology of Underreported Emerging Zoonotic Pathogen Streptococcus suis in Europe.

Molecular Epidemiology of Underreported Emerging Zoonotic Pathogen Streptococcus suis in Europe.

The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.

The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.